(Q68219544)

English

Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction

scientific article published on 01 August 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

author name string

R. Fears

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1636574

19 October 2022

J. Hearn

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1636574

19 October 2022

R. Standring

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1636574

19 October 2022

J. L. Anderson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1636574

19 October 2022

V. J. Marder

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1636574

19 October 2022

language of work or name

0 references

publication date

1 August 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:000287039290591I?httpAccept=text/xml

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

https://api.elsevier.com/content/article/PII:000287039290591I?httpAccept=text/plain

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

124

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

305-314

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris

2

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Thrombolytic therapy: current status (1).

3

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Thrombolytic therapy: current status (2).

4

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy

5

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.

6

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Biochemical pharmacology and therapeutic aspects of thrombolytic agents

7

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

8

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase

9

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator

11

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

12

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function

13

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Coronary thrombolysis and the new biology

17

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Factors influencing probability of reperfusion with intracoronary ostial infusion of thrombolytic agent in patients with acute myocardial infarction.

18

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications

20

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Lipoprotein(a), fibrin binding, and plasminogen activation.

21

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation

22

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

The clearance of heterologous protein from the circulation of normal and immunized man

23

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Consequences of antibody binding in vitro on the pharmacological properties of anisoylated plasminogen streptokinase activator complex

24

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin

26

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.

28

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Thrombolytic treatment for recurrent myocardial infarction

30

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Systemic markers of fibrinolysis after unsuccessful intracoronary streptokinase thrombolysis for acute myocardial infarction. Does nonreperfusion indicate failure to achieve a systemic lytic state?

31

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Associated reactions during and immediately after rtPA infusion

32

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction

35

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Invasive reperfusion study. II. Multicentre European randomized trial of anistreplase vs streptokinase in acute myocardial infarction

36

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Identification of patients at risk for anaphylaxis due to streptokinase

37

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Coronary patency after intravenous infusion of recombinant tissue-type plasminogen activator in acute myocardial infarction

38

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Measurement of antistreptokinase antibodies

39

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Adverse reactions to thrombolytic agents. Implications for coronary reperfusion following myocardial infarction

40

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Antistreptokinase titres after intravenous streptokinase

41

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction

43

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Thrombolytic treatment for recurrent myocardial infarction

44

1 reference

10.1016/0002-8703(92)90591-I

https://api.crossref.org/works/10.1016/0002-8703(92)90591-I

19 October 2022

Identifiers

10.1016/0002-8703(92)90591-I

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1636574%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68219544&oldid=1754005453"